8-K ·Filed Sep 16, 2026
8-K context-dependent: Items 8.01
Actionable Insight • Neutral
Routine conference presentation filing with no new material information. Monitor for any subsequent press releases or clinical/regulatory updates that may emerge from the conference.
Latest settled — T+20d
LPCN ▼ -24.32% at T+20d
NEUTRAL call -24.32% · α vs SPY -25.53% · entry $2.22 → $1.68
Latest observation: T+26 -32.82% FF3 residual α
T+1d
-0.45%
call -0.45% · α -0.33%
$2.21
settled 6w ago
T+5d
-5.86%
call -5.86% · α -6.46%
$2.09
settled 5w ago
T+20d
-24.32%
call -24.32% · α -25.53%
$1.68
settled 14d ago
T+60d
Pending
in 6w
Price Chart
Loading chart...
Executive Summary
Lipocine Inc. filed an 8-K to report that it presented at the H.C. Wainwright 28th Annual Global Investor Conference on September 16, 2026. The filing is a routine disclosure of a corporate presentation and contains no material financial data, new business developments, or regulatory updates.
Key Facts
- Lipocine presented at the H.C. Wainwright 28th Annual Global Investor Conference on September 16, 2026.
- A copy of the presentation was furnished as Exhibit 99.1 to the 8-K.
- No financial results, guidance, or material agreements were disclosed in the filing.
Financial Impact
No financial impact disclosed.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-042933 |
| Document: 0001493152-26-042933-index-headers.html | 0001493152-26-042933 |
| Document: 0001493152-26-042933-index.html | 0001493152-26-042933 |
| Document: 0001493152-26-042933.txt | 0001493152-26-042933 |
17 reports for LPCN
67% Hit rate @ T+60 Went positive at some point 4 of 5 best @ T+60▲ +11.72%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 8-K | $1.62 | awaiting T+60 | — | $1.46 (−9.88%) |
Oct 7, 2026 20d ago | 8-K | $2.20 | awaiting T+60 | — | $1.46 (−33.64%) |
Sep 16, 2026 5w ago | 8-K | $2.22 | awaiting T+60 | — | $1.46 (−34.23%) |
Sep 14, 2026 6w ago | 8-K | $2.22 | awaiting T+60 | — | $1.46 (−34.23%) |
Sep 11, 2026 6w ago | 8-K | $2.27 | awaiting T+60 | — | $1.46 (−35.68%) |
Sep 10, 2026 6w ago | 8-K | $2.25 | awaiting T+60 | — | $1.46 (−35.11%) |
Aug 4, 2026 12w ago | Press Release | $2.13 | awaiting T+60 | — | $1.46 (−31.46%) |
Aug 3, 2026 12w ago | 8-K | $2.11 $1.48 | ▼ −30.09% | ▼ −31.88% | $1.46 (−30.81%) |
Jun 4, 2026 20w ago | 8-K | $2.21 $2.17 | ▼ −1.81% | ▼ −3.69% | $1.46 (−33.94%) |
May 26, 2026 22w ago | 8-K | $2.28 $2.09 | ▼ −8.33% | ▼ −10.21% | $1.46 (−35.96%) |
Showing 10 of 17
US Market Status
Market Closed — Opens Thu (11h 52m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers